Stay Informed on Corporate Sustainability

Author: Bianca Odron

Ireland has defended its rare disease medicines framework while advancing reimbursement reform, pricing agreements and early access initiatives to improve access to orphan therapies and reduce approval delays.

Author: Bianca Odron

Kuehne+Nagel Ireland joins the Pharma Industry Awards 2026 as Title Sponsor, reinforcing its commitment to supporting innovation, quality, and operational excellence across the pharmaceutical sector. With global healthcare logistics expertise and a strong focus on compliance and sustainability, the company continues to play a key role in enabling pharmaceutical supply chains worldwide.

Author: Bianca Odron

Equans Sci-Tech joins the Pharma Industry Awards UK as Platinum Sponsor, reflecting its expertise in delivering specialist pharmaceutical environments and supporting excellence across regulated facilities, technical delivery, and long-term operational performance.

Author: Bianca Odron

BioMarin Pharmaceutical has won Workplace of the Year at the Women in Pharma Awards 2026, recognising its commitment to building an inclusive, engaging workplace culture that supports employees, innovation, and patient outcomes.

Author: Bianca Odron

Trend Technologies has won the Sustainability Award at the Life Sciences Industry Awards 2026 for embedding environmental and social responsibility through operational improvements, employee initiatives, and long-term sustainable business practices.

Author: Bianca Odron

Trane's CEO says most buildings waste 30% of their energy, a finding that lands directly on Ireland's new BER regulations and EU energy efficiency mandates now reshaping facilities management priorities.

Author: Bianca Odron

CCRM, OmniaBio and Avectas will evaluate an automated manufacturing platform designed for cell therapy production. The collaboration reflects growing industry focus on scalability, standardisation and manufacturing efficiency in advanced therapies.

Author: Bianca Odron

Jazz Pharmaceuticals and PharmaMar reported a Phase III setback for Zepzelca in relapsed small-cell lung cancer. The outcome highlights ongoing pressure on oncology development, evidence requirements and treatment competition.

Author: Bianca Odron

WuXi Biologics secured both Life Sciences Team of the Year and Overall Excellence in Life Sciences at the Life Sciences Industry Awards 2026, recognising the outstanding achievements of its Manufacturing Science & Technology Team.

Author: Bianca Odron

Ireland has the potential to expand its role in cannabinoid medicine manufacturing through investment, regulation and scientific expertise. Industry leaders say stronger support could help scale domestic pharmaceutical innovation.